Axi-cel as a safe and effective treatment in older patients with large B-cell lymphoma.

Panopoulou, Aikaterini; O'Reilly, Maeve; Roddie, Claire

Panopoulou, Aikaterini; O'Reilly, Maeve; Roddie, Claire.

Afiliación

Panopoulou A; Department of Haematology, University College London Hospitals (UCLH), London, UK.
O'Reilly M; Department of Haematology, University College London Hospitals (UCLH), London, UK; Department of Haematology, University College London (UCL) Cancer Institute, London, UK.
Roddie C; Department of Haematology, University College London Hospitals (UCLH), London, UK; Department of Haematology, University College London (UCL) Cancer Institute, London, UK.

Ann Palliat Med ; 13(2): 458-461, 2024 Mar.

Article en En | MEDLINE | ID: mdl-38509649

Asunto(s)

Linfoma de Células B; Humanos; Anciano; Resultado del Tratamiento; Linfoma de Células B/terapia

Palabras clave

Axicabtagene ciloleucel (axi-cel); elderly; event-free survival (EFS)

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfoma de Células B Límite: Aged / Humans Idioma: En Revista: Ann Palliat Med Año: 2024 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google